More from the Author

• Supplement | HBS Case Collection | January 2018 (Revised May 2018)

  Wanxiang Group: A Chinese Company's Global Strategy (C)

  William C. Kirby, Yuanzhuo Wang, William C. Kirby and Yuanzhuo Wang

  This case updates Wanxiang Group's activities since 2012, focusing on its electric vehicle strategy and a transition of the group's leadership.

  Keywords: electric vehicles; leadership succession; Strategy; Management Succession; Global Range; Auto Industry; United States; China;

  Citation:

  Kirby, William C., and Yuanzhuo Wang. "Wanxiang Group: A Chinese Company's Global Strategy (C)." Harvard Business School Supplement 318-091, January 2018. (Revised May 2018.)  View Details

  CiteView DetailsPurchase

  Related

• Supplement | HBS Case Collection | January 2018 (Revised May 2018)

  Wanxiang Group: A Chinese Company's Global Strategy (C)

  William C. Kirby, Yuanzhuo Wang, William C. Kirby and Yuanzhuo Wang

  This case updates Wanxiang Group's activities since 2012, focusing on its electric vehicle strategy and a transition of the group's leadership.

  Keywords: electric vehicles; leadership succession; Strategy; Management Succession; Global Range; Auto Industry; United States; China;

  Citation:

  Kirby, William C., and Yuanzhuo Wang. "Wanxiang Group: A Chinese Company's Global Strategy (C)." Harvard Business School Supplement 318-091, January 2018. (Revised May 2018.)  View Details

  CiteView DetailsPurchase

  Related

• Case | HBS Case Collection | February 2018 (Revised April 2018)

  Yunnan Baiyao: Transforming a Chinese State-Owned Enterprise

  Michael Chu, William C. Kirby, Nancy Hua Dai, Yuanzhuo Wang, Michael Chu, William C. Kirby, Nancy Hua Dai and Yuanzhuo Wang

  This case tells the story of how Wang Minghui, Chairman of Yunnan Baiyao Group since 1999, transformed a single-product traditional Chinese medicine (TCM) state-owned enterprise (SOE) into a major diversified consumer health player in China's highly competitive fast-moving consumer goods market. The case also traces the development of the company from a private business to a SOE and then to a SOE under mixed state-private ownership.

  Keywords: state-owned enterprise (SOE); competition; traditional chinese medicine; Yunnan; Yunnan Baiyao; consumer health; enterprise transformation; Transformation; Health; Business History; State Ownership; Private Ownership; Business Strategy; Commercialization; Competition; Consumer Products Industry; Health Industry; Pharmaceutical Industry; China;

  Citation:

  Chu, Michael, William C. Kirby, Nancy Hua Dai, and Yuanzhuo Wang. "Yunnan Baiyao: Transforming a Chinese State-Owned Enterprise." Harvard Business School Case 318-078, February 2018. (Revised April 2018.)  View Details

  CiteView DetailsEducators

  Related